Abrocitinib ( DrugBank: Abrocitinib )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
84	サルコイドーシス	1

84. サルコイドーシス

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05696795 (ClinicalTrials.gov)	May 1, 2023	13/1/2023	Janus Kinase Inhibition in Sarcoidosis	JAK1 Inhibition in Sarcoidosis: an Opportunity for Pathogenesis Directed Therapy	Sarcoidosis	Drug: Abrocitinib 200 mg	Yale University	Pfizer	Not yet recruiting	18 Years	N/A	All	10	Phase 2	United States